Product Pipeline
Find out about the anti-cancer drugs we have in development
Press Releases
-
Taiho Oncology to Present Data at the 66th American Society of Hematology Annual Meeting
-
Taiho Oncology Announces Publication of Final Results of the Phase 3 ASCERTAIN Clinical Trial of Oral Decitabine and Cedazuridine Fixed Dose Combination (INQOVI®) in Patients With MDS and CMML
-
Taiho Oncology Announces Presentation of Data From a U.S. Real-World Study of Oral Decitabine and Cedazuridine